Welcure Drugs and Pharmaceuticals Limited (BOM:524661)
India flag India · Delayed Price · Currency is INR
0.280
-0.010 (-3.45%)
At close: Mar 10, 2026

BOM:524661 Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
3461,023515413225
Upgrade
Market Cap Growth
-66.78%1913.04%-6.47%-58.85%419.68%370.01%
Upgrade
Enterprise Value
1,5771,020504013225
Upgrade
Last Close Price
0.280.830.340.370.890.17
Upgrade
PE Ratio
1.0847.13-53.41559.8746.06
Upgrade
PS Ratio
0.094.17--125.7319.05
Upgrade
PB Ratio
0.261.003.793.59141.9536.59
Upgrade
P/TBV Ratio
0.261.003.793.59141.9536.59
Upgrade
P/FCF Ratio
---50.81711.5660.22
Upgrade
P/OCF Ratio
---50.81711.5660.22
Upgrade
EV/Sales Ratio
0.434.16--125.6418.94
Upgrade
EV/EBITDA Ratio
3.5336.6141.2989.54--
Upgrade
EV/EBIT Ratio
3.5336.7158.4896.55559.4745.90
Upgrade
EV/FCF Ratio
---37.12711.0659.86
Upgrade
Debt / Equity Ratio
0.921.20----
Upgrade
Debt / EBITDA Ratio
2.7644.19----
Upgrade
Net Debt / Equity Ratio
0.921.20-0.020.00-0.71-0.68
Upgrade
Net Debt / EBITDA Ratio
2.7544.15-0.18-0.03--
Upgrade
Net Debt / FCF Ratio
--0.550.17-0.01-3.56-1.12
Upgrade
Asset Turnover
-0.18--1.242.73
Upgrade
Quick Ratio
-0.460.710.0917.3013.21
Upgrade
Current Ratio
-4.411.040.4317.3013.21
Upgrade
Return on Equity (ROE)
-4.18%-12.24%12.65%29.03%131.74%
Upgrade
Return on Assets (ROA)
-1.29%3.72%3.16%17.36%70.45%
Upgrade
Return on Invested Capital (ROIC)
16.79%1.24%6.09%5.33%96.32%355.34%
Upgrade
Return on Capital Employed (ROCE)
-1.20%6.40%2.70%25.40%79.20%
Upgrade
Earnings Yield
128.93%2.12%-3.44%1.87%0.18%2.17%
Upgrade
FCF Yield
--217.11%-2.51%1.97%0.14%1.66%
Upgrade
Buyback Yield / Dilution
-78.83%-477.75%-0.54%-10.90%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.